Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

716 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT Jr, Whelton PK, Barzilay J, Batuman V, Eckfeldt JH, Farber M, Henriquez M, Kopyt N, Louis GT, Saklayen M, Stanford C, Walworth C, Ward H, Wiegmann T. Rahman M, et al. Among authors: farber m. Arch Intern Med. 2005 Apr 25;165(8):936-46. doi: 10.1001/archinte.165.8.936. Arch Intern Med. 2005. PMID: 15851647 Clinical Trial.
Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate.
Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT Jr, Whelton PK, Barzilay J, Batuman V, Eckfeldt JH, Farber MA, Franklin S, Henriquez M, Kopyt N, Louis GT, Saklayen M, Stanford C, Walworth C, Ward H, Wiegmann T; ALLHAT Collaborative Research Group. Rahman M, et al. Among authors: farber ma. Ann Intern Med. 2006 Feb 7;144(3):172-80. doi: 10.7326/0003-4819-144-3-200602070-00005. Ann Intern Med. 2006. PMID: 16461961 Clinical Trial.
Relationship of antihypertensive treatment regimens and change in blood pressure to risk for heart failure in hypertensive patients randomly assigned to doxazosin or chlorthalidone: further analyses from the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial.
Davis BR, Cutler JA, Furberg CD, Wright JT, Farber MA, Felicetta JV, Stokes JD; ALLHAT Collaborative Research Group. Davis BR, et al. Ann Intern Med. 2002 Sep 3;137(5 Part 1):313-20. doi: 10.7326/0003-4819-137-5_part_1-200209030-00006. Ann Intern Med. 2002. PMID: 12204014 Clinical Trial.
Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
Davis BR, Kostis JB, Simpson LM, Black HR, Cushman WC, Einhorn PT, Farber MA, Ford CE, Levy D, Massie BM, Nawaz S; ALLHAT Collaborative Research Group. Davis BR, et al. Among authors: farber ma. Circulation. 2008 Nov 25;118(22):2259-67. doi: 10.1161/CIRCULATIONAHA.107.762229. Epub 2008 Nov 10. Circulation. 2008. PMID: 19001024 Free PMC article. Clinical Trial.
Cryptococcal bursitis.
Sepkowitz D, Maslow M, Farber M, Seleznick M, Walker R. Sepkowitz D, et al. Among authors: farber m. Ann Intern Med. 1988 Jan;108(1):154. doi: 10.7326/0003-4819-108-1-154_1. Ann Intern Med. 1988. PMID: 3337503 No abstract available.
A depletion syndrome in villous adenoma of the rectum.
RABINOWITZ P, FARBER M, FRIEDMAN IS. RABINOWITZ P, et al. Among authors: farber m. Arch Intern Med. 1962 Mar;109:265-9. doi: 10.1001/archinte.1962.03620150015003. Arch Intern Med. 1962. PMID: 14489625 No abstract available.
Practice Patterns of Antiplatelet and Anticoagulant Therapy After Fenestrated/Branched Endovascular Aortic Repair.
Fan EY, Schanzer A, Beck AW, Eagleton MJ, Farber MA, Gasper WJ, Lee WA, Oderich GS, Parodi FE, Schneider DB, Sweet MP, Timaran CH, Simons JP; US Aortic Research Consortium. Fan EY, et al. Among authors: farber ma. J Vasc Surg. 2024 May 23:S0741-5214(24)01220-5. doi: 10.1016/j.jvs.2024.05.041. Online ahead of print. J Vasc Surg. 2024. PMID: 38796031
Effect of Family History of Aortic Disease on Outcomes of Fenestrated/Branched Endovascular Aneurysm Repair of Complex Aortic Aneurysms.
Sulzer TAL, Mesnard T, Schanzer A, Timaran CH, Schneider DB, Farber MA, Beck AW, Huang Y, Oderich GS; United States Aortic Research Consortium. Sulzer TAL, et al. Among authors: farber ma. Eur J Vasc Endovasc Surg. 2024 May 13:S1078-5884(24)00389-7. doi: 10.1016/j.ejvs.2024.05.011. Online ahead of print. Eur J Vasc Endovasc Surg. 2024. PMID: 38750880
Preoperative risk factors for 1-year mortality in patients undergoing fenestrated endovascular aortic aneurysm repair in the US Aortic Research Consortium.
Banks CA, Novak Z, Spangler EL, Schanzer A, Farber MA, Sweet MP, Oderich G, Timaran CH, Lee A, Schneider DB, Eagleton MJ, Gasper W, Beck AW. Banks CA, et al. Among authors: farber ma. J Vasc Surg. 2024 May 6:S0741-5214(24)01089-9. doi: 10.1016/j.jvs.2024.04.063. Online ahead of print. J Vasc Surg. 2024. PMID: 38718849
716 results